SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-010905
Filing Date
2019-05-28
Accepted
2019-05-28 16:44:46
Documents
12
Period of Report
2019-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20190525_8k.htm 8-K 37725
2 EXHIBIT 4.1 ex_145858.htm EX-4.1 106424
3 EXHIBIT 4.2 ex_145859.htm EX-4.2 113983
4 EXHIBIT 5.1 ex_145860.htm EX-5.1 12429
5 EXHIBIT 10.1 ex_145861.htm EX-10.1 229019
6 EXHIBIT 10.2 ex_145862.htm EX-10.2 58169
7 EXHIBIT 99.1 ex_145863.htm EX-99.1 14166
8 EXHIBIT 99.2 ex_145926.htm EX-99.2 13833
9 a1.jpg GRAPHIC 11073
10 ex_145926img001.jpg GRAPHIC 3828
11 image0x.jpg GRAPHIC 6306
12 image0y.jpg GRAPHIC 4703
  Complete submission text file 0001437749-19-010905.txt   618037
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 19858361
SIC: 2834 Pharmaceutical Preparations